Related Experiment Video
Updated: Sep 25, 2025

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha
Konda Reddy Karnati1, Yixuan Wang1, Yongli Du2
1Department of Chemistry and Forensic Science, Albany State University Albany GA 31705 USA yixuan.wang@asurams.edu.
Abstract:
Since estrogen-related receptor alpha (ERRα), one of three estrogen-related receptors, displays constitutively active transcriptional activities and important implications in both physiological and pathological processes of breast cancers, ERRα was recently recognized as a new target to fight breast cancers, and regulating the activity of ERRα with inverse agonists has thus become a promising new therapeutic strategy. A few inverse agonists cyclohexylmethyl-(1-p-tolyl-1H-indol-3-ylmethyl)-amine (compound 1), thiadiazoacrylamide (XCT790), and 1-(2,5-diethoxy-benzyl)-3-phenyl-area analogues (compounds 2 and 3) were reported to be capable of targeting ERRα. However, the detailed mechanism by which the inverse agonists deactivate ERRα remains unclear, especially in the aspects of quantitative binding and hot spot residues. Therefore, to gain insights into the interaction modes between inverse agonists and ERRα ligand binding domain, all-atom molecular dynamics (MD) simulations were firstly carried out for the complexes of inverse agonists and ERRα. The binding free energies were then calculated with MM-PBSA method to quantitatively discuss the binding of the inverse agonists with ERRα. The binding affinities were finally decomposed to per-residue contributions to identify the hot spot residues as well as assess their role in the binding mechanism. MD simulations show that the inverse agonists stretch downwards into the ERRα ligand binding pocket (LBP) formed by H3 and H11 helices, and upon the binding H12 adopts a well-defined position in the coactivator groove, where PGC-1α binds to ERRα. Binding energy analysis indicates that compound 3 and XCT790 bind more tightly to ERRα than compounds 1 and 2, and the energy difference mainly results from the contribution of van der Waals interaction. Both binding mode analysis and affinity decomposition per-residue indicate that compound 1, XCT790, and compound 3 have similar binding spectra to ERRα, primarily interacting with the residues of H3, H5, H6/H7 loop, and H11 helix, while compound 2 lacks a significant interaction with the H5 region. The hot spot residues significantly binding to the three inverse agonists in common include Leu324, Phe328, Phe382, Leu398, Phe495, and Leu500. It is essential for an effective inverse agonist to strongly bind with the aromatic ring cluster consisting of Phe328(H3), Phe495(H11), and Phe382(H5/H6 loop) as well as Leu500.
Insights
Estrogen-related receptor alpha (ERRα) inverse agonists show promise for breast cancer therapy. Molecular dynamics simulations reveal key binding interactions and identify critical "hot spot" residues for drug development.
Area of Science:
- Molecular biology
- Structural biology
- Pharmacology
Background:
- Estrogen-related receptor alpha (ERRα) is a validated target for breast cancer treatment.
- Inverse agonists are a promising therapeutic strategy for regulating ERRα activity.
- The precise binding mechanisms and key residues involved in ERRα inverse agonism remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms of ERRα inverse agonism.
- To quantitatively assess the binding affinities of known inverse agonists to ERRα.
- To identify critical
Main Methods:
- All-atom molecular dynamics (MD) simulations were performed on complexes of inverse agonists and ERRα.
- Binding free energies were calculated using the MM-PBSA method.
- Binding affinities were decomposed per residue to identify hot spot residues.
Main Results:
- MD simulations revealed that inverse agonists bind within the ERRα ligand binding pocket (LBP), positioning helix H12 in the coactivator groove.
- Compound 3 and XCT790 exhibited stronger binding to ERRα than compounds 1 and 2, primarily due to van der Waals interactions.
- Common hot spot residues for effective binding across multiple inverse agonists include Leu324, Phe328, Phe382, Leu398, Phe495, and Leu500.
Conclusions:
- The study provides detailed insights into the binding modes of ERRα inverse agonists.
- Key residues and interactions essential for potent ERRα inhibition were identified.
- These findings are crucial for the rational design of novel breast cancer therapeutics targeting ERRα.
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...

